The Nasdaq Composite is the only major stock index that hasn't put the 2022 bear market in the rearview mirror. For patient investors, it means bargains still abound.
The growth-fueled Nasdaq Composite remains nearly 6% below its all-time high, which means amazing deals can still be found.
These healthcare businesses are compelling buys for very different reasons.
The growth-fueled Nasdaq Composite remains 7% below its all-time high, which means bargains can still be found.
You don't need a mountain of cash to build wealth on Wall Street.
Leveraging a favorable DEA classification for its synthetic analog of THC, Mira Pharmaceuticals could be on an expedited pathway toward commercialization to treat several unmet neurological m
Many biotech stocks offer exciting long-term growth prospects.
A modest amount of money can go a long way when it's invested in inexpensive, game-changing businesses.